| # | Title | Journal | Year | Citations |
|---|
| 1 | Association of Cardiac Injury With Mortality in Hospitalized Patients With COVID-19 in Wuhan, China | JAMA Cardiology | 2020 | 3,373 |
| 2 | Cardiovascular Implications of Fatal Outcomes of Patients With Coronavirus Disease 2019 (COVID-19) | JAMA Cardiology | 2020 | 3,210 |
| 3 | Outcomes of Cardiovascular Magnetic Resonance Imaging in Patients Recently Recovered From Coronavirus Disease 2019 (COVID-19) | JAMA Cardiology | 2020 | 1,659 |
| 4 | Potential Effects of Coronaviruses on the Cardiovascular System | JAMA Cardiology | 2020 | 1,469 |
| 5 | Cardiac Involvement in a Patient With Coronavirus Disease 2019 (COVID-19) | JAMA Cardiology | 2020 | 1,465 |
| 6 | Association of Cardiac Infection With SARS-CoV-2 in Confirmed COVID-19 Autopsy Cases | JAMA Cardiology | 2020 | 644 |
| 7 | Association of SGLT2 Inhibitors With Cardiovascular and Kidney Outcomes in Patients With Type 2 Diabetes | JAMA Cardiology | 2021 | 625 |
| 8 | Association of Body Mass Index With Lifetime Risk of Cardiovascular Disease and Compression of Morbidity | JAMA Cardiology | 2018 | 591 |
| 9 | Risk of QT Interval Prolongation Associated With Use of Hydroxychloroquine With or Without Concomitant Azithromycin Among Hospitalized Patients Testing Positive for Coronavirus Disease 2019 (COVID-19) | JAMA Cardiology | 2020 | 567 |
| 10 | Associations of Omega-3 Fatty Acid Supplement Use With Cardiovascular Disease Risks | JAMA Cardiology | 2018 | 526 |
| 11 | Association of Age at Onset of Menopause and Time Since Onset of Menopause With Cardiovascular Outcomes, Intermediate Vascular Traits, and All-Cause Mortality | JAMA Cardiology | 2016 | 520 |
| 12 | Systolic Blood Pressure Reduction and Risk of Cardiovascular Disease and Mortality | JAMA Cardiology | 2017 | 515 |
| 13 | Association of Renin-Angiotensin System Inhibitors With Severity or Risk of Death in Patients With Hypertension Hospitalized for Coronavirus Disease 2019 (COVID-19) Infection in Wuhan, China | JAMA Cardiology | 2020 | 484 |
| 14 | Association of Coronavirus Disease 2019 (COVID-19) With Myocardial Injury and Mortality | JAMA Cardiology | 2020 | 471 |
| 15 | Association ofLPAVariants With Risk of Coronary Disease and the Implications for Lipoprotein(a)-Lowering Therapies | JAMA Cardiology | 2018 | 428 |
| 16 | Myocarditis Following Immunization With mRNA COVID-19 Vaccines in Members of the US Military | JAMA Cardiology | 2021 | 423 |
| 17 | Burden of Cardiovascular Diseases in China, 1990-2016 | JAMA Cardiology | 2019 | 417 |
| 18 | Recent Trends in Cardiovascular Mortality in the United States and Public Health Goals | JAMA Cardiology | 2016 | 405 |
| 19 | Cardiovascular Magnetic Resonance Findings in Competitive Athletes Recovering From COVID-19 Infection | JAMA Cardiology | 2021 | 361 |
| 20 | Passive Detection of Atrial Fibrillation Using a Commercially Available Smartwatch | JAMA Cardiology | 2018 | 357 |
| 21 | Effect of Monthly High-Dose Vitamin D Supplementation on Cardiovascular Disease in the Vitamin D Assessment Study | JAMA Cardiology | 2017 | 353 |
| 22 | Association of Use of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers With Testing Positive for Coronavirus Disease 2019 (COVID-19) | JAMA Cardiology | 2020 | 350 |
| 23 | Use of High-Risk Coronary Atherosclerotic Plaque Detection for Risk Stratification of Patients With Stable Chest Pain | JAMA Cardiology | 2018 | 349 |
| 24 | Association of the Hospital Readmissions Reduction Program Implementation With Readmission and Mortality Outcomes in Heart Failure | JAMA Cardiology | 2018 | 346 |
| 25 | Comparison of Coronary CT Angiography, SPECT, PET, and Hybrid Imaging for Diagnosis of Ischemic Heart Disease Determined by Fractional Flow Reserve | JAMA Cardiology | 2017 | 324 |
| 26 | Accuracy of Wrist-Worn Heart Rate Monitors | JAMA Cardiology | 2017 | 313 |
| 27 | Association of Mutations Contributing to Clonal Hematopoiesis With Prognosis in Chronic Ischemic Heart Failure | JAMA Cardiology | 2019 | 313 |
| 28 | Associations of Combined Genetic and Lifestyle Risks With Incident Cardiovascular Disease and Diabetes in the UK Biobank Study | JAMA Cardiology | 2018 | 310 |
| 29 | Multicenter Study of Planar Technetium 99m Pyrophosphate Cardiac Imaging | JAMA Cardiology | 2016 | 304 |
| 30 | Apolipoprotein B Particles and Cardiovascular Disease | JAMA Cardiology | 2019 | 299 |
| 31 | National Trends in Statin Use and Expenditures in the US Adult Population From 2002 to 2013 | JAMA Cardiology | 2017 | 297 |
| 32 | Seasonal Influenza Infections and Cardiovascular Disease Mortality | JAMA Cardiology | 2016 | 289 |
| 33 | Effects of Sodium-Glucose Cotransporter 2 Inhibitors for the Treatment of Patients With Heart Failure | JAMA Cardiology | 2017 | 280 |
| 34 | The Burden of Cardiovascular Diseases Among US States, 1990-2016 | JAMA Cardiology | 2018 | 271 |
| 35 | Perioperative Major Adverse Cardiovascular and Cerebrovascular Events Associated With Noncardiac Surgery | JAMA Cardiology | 2017 | 268 |
| 36 | A New Equation for Calculation of Low-Density Lipoprotein Cholesterol in Patients With Normolipidemia and/or Hypertriglyceridemia | JAMA Cardiology | 2020 | 259 |
| 37 | Association of Coronary Artery Calcium in Adults Aged 32 to 46 Years With Incident Coronary Heart Disease and Death | JAMA Cardiology | 2017 | 254 |
| 38 | Patients With Acute Myocarditis Following mRNA COVID-19 Vaccination | JAMA Cardiology | 2021 | 254 |
| 39 | Vitamin D Supplementation and Cardiovascular Disease Risks in More Than 83 000 Individuals in 21 Randomized Clinical Trials | JAMA Cardiology | 2019 | 253 |
| 40 | Associations of Obstructive Sleep Apnea With Atrial Fibrillation and Continuous Positive Airway Pressure Treatment | JAMA Cardiology | 2018 | 252 |
| 41 | Coronary Artery Calcification and Risk of Cardiovascular Disease and Death Among Patients With Chronic Kidney Disease | JAMA Cardiology | 2017 | 251 |
| 42 | Oral Anticoagulant Therapy Prescription in Patients With Atrial Fibrillation Across the Spectrum of Stroke Risk | JAMA Cardiology | 2016 | 249 |
| 43 | Prediction of 30-Day All-Cause Readmissions in Patients Hospitalized for Heart Failure | JAMA Cardiology | 2017 | 249 |
| 44 | Sex Differences in Blood Pressure Trajectories Over the Life Course | JAMA Cardiology | 2020 | 249 |
| 45 | Adult Stem Cell Therapy and Heart Failure, 2000 to 2016 | JAMA Cardiology | 2016 | 248 |
| 46 | Prevalence of Clinical and Subclinical Myocarditis in Competitive Athletes With Recent SARS-CoV-2 Infection | JAMA Cardiology | 2021 | 244 |
| 47 | Association of Lipid Fractions With Risks for Coronary Artery Disease and Diabetes | JAMA Cardiology | 2016 | 233 |
| 48 | A Population-Based Study of Cardiovascular Mortality Following Early-Stage Breast Cancer | JAMA Cardiology | 2017 | 232 |
| 49 | Development and Validation of a Risk Prediction Model for In-Hospital Mortality After Transcatheter Aortic Valve Replacement | JAMA Cardiology | 2016 | 230 |
| 50 | Characteristics Associated With Out-of-Hospital Cardiac Arrests and Resuscitations During the Novel Coronavirus Disease 2019 Pandemic in New York City | JAMA Cardiology | 2020 | 230 |
